Cost of Treatment for Myelofibrosis Patients in Ministry of Health Hospitals in Sarawak, Malaysia.

Asian Pac J Cancer Prev · 2023 · PMC10334073 · PMID 36974524

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The mean annualised drug cost shows an increasing trend by line of therapy from RM7,142 per patient per year for first-line therapy to approximately RM30,000 in second- and third-line respectively, and RM51,878 for fourth-line therapy.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.